Reltecimod
Description
Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs).
Product Information
| Product Name | Reltecimod |
| Molecular Weight | 1037.19 |
| Formula | C46H72N10O15S |
| CAS Number | 1447799-33-8 |
| Appearance | Solid |
| Color | White to off-white |
| Sequence | {d-Ala}-Ser-Pro-Met-Leu-Val-Ala-Tyr-Asp-{d-Ala} |
| Sequence Shortening | {d-Ala}-SPMLVAYD-{d-Ala} |
| Storage | Sealed storage, away from moisture Powder -80??C 2 years -20??C 1 year *In solvent : -80??C, 6 months; -20??C, 1 month (sealed storage, away from moisture) |
